A mouse model for Finnish variant late infantile neuronal ceroid lipofuscinosis, CLN5, reveals neuropathology associated with early aging.

Neuronal ceroid lipofuscinoses (NCL) comprise the most common group of childhood encephalopathies caused by mutations in eight genetic loci, CLN1-CLN8. Here, we have developed a novel mouse model for the human vLINCL (CLN5) by targeted deletion of exon 3 of the mouse Cln5 gene. The Cln5-/- mice showed loss of vision and accumulation of autofluorescent storage material in the central nervous system (CNS) and peripheral tissues without prominent brain atrophy. The ultrastructure of the storage material accurately replicated the abnormalities in human patients revealing mixture of lamellar profiles including fingerprint profiles as well as curvilinear and rectilinear bodies in electronmicroscopic analysis. Prominent loss of a subset of GABAergic interneurons in several brain areas was seen in the Cln5-/- mice. Transcript profiling of the brains of the Cln5-/- mice revealed altered expression in several genes involved in neurodegeneration, as well as in defense and immune response, typical of age-associated changes in the CNS. Downregulation of structural components of myelin was detected and this agrees well with the hypomyelination seen in the human vLINCL patients. In general, the progressive pathology of the Cln5-/- brain mimics the symptoms of the corresponding neurodegenerative disorder in man. Since the Cln5-/- mice do not exhibit significant brain atrophy, these mice could serve as models for studies on molecular processes associated with advanced aging.

[1]  R. N. Saha,et al.  Tumor necrosis factor‐α at the crossroads of neuronal life and death during HIV‐associated dementia , 2003, Journal of neurochemistry.

[2]  M. Daly,et al.  PGC-1α-responsive genes involved in oxidative phosphorylation are coordinately downregulated in human diabetes , 2003, Nature Genetics.

[3]  M. Beal.  Mitochondria, Oxidative Damage, and Inflammation in Parkinson's Disease , 2003, Annals of the New York Academy of Sciences.

[4]  J. Cooper.  Progress towards understanding the neurobiology of Batten disease or neuronal ceroid lipofuscinosis , 2003, Current opinion in neurology.

[5]  A. Brooks,et al.  Early changes in gene expression in two models of Batten disease , 2003, FEBS letters.

[6]  M. Haltia.  The Neuronal Ceroid–Lipofuscinoses , 2003, Journal of neuropathology and experimental neurology.

[7]  P. Guarneri,et al.  Mitochondrial oxidative metabolism in motor neuron degeneration (mnd) mouse central nervous system , 2002, The European journal of neuroscience.

[8]  A. Vezzani,et al.  Expression of glutamate receptor subtypes in the spinal cord of control and mnd mice, a model of motor neuron disorder , 2002, Journal of neuroscience research.

[9]  M. Carson.  Microglia as liaisons between the immune and central nervous systems: Functional implications for multiple sclerosis , 2002, Glia.

[10]  T. Lerner,et al.  Cln3(Deltaex7/8) knock-in mice with the common JNCL mutation exhibit progressive neurologic disease that begins before birth. , 2002, Human molecular genetics.

[11]  P. Aisen.  Anti-inflammatory agents in Alzheimer’s disease , 2002, Current neurology and neuroscience reports.

[12]  L. Peltonen,et al.  Neuronal ceroid lipofuscinoses are connected at molecular level: interaction of CLN5 protein with CLN2 and CLN3. , 2002, Molecular biology of the cell.

[13]  E. Tarkowski.  Cytokines in dementias. , 2002, Current drug targets. Inflammation and allergy.

[14]  R. Proia,et al.  Molecular pathophysiology in Tay-Sachs and Sandhoff diseases as revealed by gene expression profiling. , 2002, Human molecular genetics.

[15]  L. Peltonen,et al.  Lysosomal localization of the neuronal ceroid lipofuscinosis CLN5 protein. , 2002, Human molecular genetics.

[16]  J. Warrington,et al.  Identification and validation of endogenous reference genes for expression profiling of T helper cell differentiation by quantitative real-time RT-PCR. , 2001, Analytical biochemistry.

[17]  R. Hammer,et al.  Disruption of PPT1 or PPT2 causes neuronal ceroid lipofuscinosis in knockout mice , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[18]  C. Scriver,et al.  The Metabolic and Molecular Bases of Inherited Disease, 8th Edition 2001 , 2001, Journal of Inherited Metabolic Disease.

[19]  R. Proia,et al.  Microglial activation precedes acute neurodegeneration in Sandhoff disease and is suppressed by bone marrow transplantation. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[20]  L. Peltonen,et al.  Phenotype–genotype correlation in eight patients with Finnish variant late infantile NCL (CLN5) , 2000, Neurology.

[21]  Richard Weindruch,et al.  Gene-expression profile of the ageing brain in mice , 2000, Nature Genetics.

[22]  M. Ashburner,et al.  Gene Ontology: tool for the unification of biology , 2000, Nature Genetics.

[23]  T. Paunio,et al.  Expression of palmitoyl protein thioesterase in neurons. , 2000, Molecular genetics and metabolism.

[24]  Jonathan D. Cooper,et al.  Targeted Disruption of the Cln3 Gene Provides a Mouse Model for Batten Disease , 1999, Neurobiology of Disease.

[25]  G. Johnson,et al.  A mouse gene knockout model for juvenile ceroid‐lipofuscinosis (batten disease) , 1999, Journal of neuroscience research.

[26]  W. Mobley,et al.  Apparent Loss and Hypertrophy of Interneurons in a Mouse Model of Neuronal Ceroid Lipofuscinosis: Evidence for Partial Response to Insulin-Like Growth Factor-1 Treatment , 1999, The Journal of Neuroscience.

[27]  E. Lander,et al.  CLN5, a novel gene encoding a putative transmembrane protein mutated in Finnish variant late infantile neuronal ceroid lipofuscinosis , 1998, Nature Genetics.

[28]  L. Donahue,et al.  Neuronal ceroid lipofuscinosis (nclf), a new disorder of the mouse linked to chromosome 9. , 1998, American journal of medical genetics.

[29]  K. Becker.  Inflammation and acute stroke. , 1998, Current opinion in neurology.

[30]  E. Fisher,et al.  Behavioral and functional analysis of mouse phenotype: SHIRPA, a proposed protocol for comprehensive phenotype assessment , 1997, Mammalian Genome.

[31]  J. Suopanki,et al.  Variant Late Infantile Neuronal Ceroid‐lipofuscinosis: Pathology and Biochemistry , 1997, Journal of neuropathology and experimental neurology.

[32]  S. Walkley,et al.  Morphological alterations in neocortical and cerebellar GABAergic neurons in a canine model of juvenile Batten disease. , 1995, American journal of medical genetics.

[33]  L. Peltonen,et al.  Defined chromosomal assignment of CLN5 demonstrates that at least four genetic loci are involved in the pathogenesis of human ceroid lipofuscinoses. , 1994, American journal of human genetics.

[34]  A. Messer,et al.  Accumulating autofluorescent material as a marker for early changes in the spinal cord of the Mnd mouse , 1993, Neuromuscular Disorders.

[35]  R. Bronson,et al.  Motor neuron degeneration of mice is a model of neuronal ceroid lipofuscinosis (Batten's disease) , 1993, Annals of neurology.

[36]  T. Autti,et al.  Jansky-Bielschowsky variant disease: CT, MRI, and SPECT findings. , 1992, Pediatric neurology.

[37]  H. Braak,et al.  Pigmentoarchitectonic pathology of the isocortex in juvenile neuronal ceroid-lipofuscinosis: Axonal enlargements in layer IIIab and cell loss in layer V , 1979, Acta Neuropathologica.

[38]  H. Braak,et al.  Loss of pigment-laden stellate cells: A severe alteration of the isocortex in juvenile neuronal ceroid-lipofuscinosis , 1978, Acta Neuropathologica.

[39]  R. S. Williams,et al.  The cellular pathology of neuronal ceroid-lipofuscinosis. A golgi-electronmicroscopic study. , 1977, Archives of neurology.

[40]  C. Tilikete,et al.  Pre- and postnatal enzyme analysis for infantile, late infantile and adult neuronal ceroid lipofuscinosis (CLN 1 and CLN2) , 2001 .

[41]  C. Tilikete,et al.  Pre- and postnatal enzyme analysis for infantile, late infantile and adult neuronal ceroid lipofuscinosis (CLN1 and CLN2). , 2001, European journal of paediatric neurology : EJPN : official journal of the European Paediatric Neurology Society.

[42]  Sara E. Mole,et al.  CLN5 – Finnish variant late infantile NCL , 1999 .

[43]  S. Mole.  Neuronal ceroid lipofuscinoses. , 1999, European journal of paediatric neurology : EJPN : official journal of the European Paediatric Neurology Society.

[44]  M. Filbin,et al.  Purification and characterization of plasma membranes obtained from rat neurons prepared by bulk‐isolation , 1986, Journal of neuroscience research.